Gilead Sciences Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Gilead Sciences Inc
TickerGILD
CIK #0000882095
CUSIP375558103
SectorLife Sciences - Biological Products, (No Disgnostic Substances)
Address333 Lakeside Dr, Foster City, CA 94404
Source [EDGAR]
CIK Filing 2011 - 2025
[0000882095] 10-K
[0000882095] 10-Q
[0000882095] 13F-HR
[0000882095] 3
[0000882095] 4
[0000882095] 5
[0000882095] 8-K
[0000882095] SC 13D
[0000882095] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Gilead Sciences Inc LEAP Therapeutics Inc [2024-04-19] 819413.9
Gilead Sciences Inc Xilio Therapeutics Inc [2024-04-05] 819419.9
Gilead Sciences Inc Kyverna Therapeutics Inc [2024-02-20] 8194.0
Gilead Sciences Inc Assembly Biosciences Inc [2023-10-25] 19.9
Gilead Sciences Inc Ikena Oncology Inc [2023-10-19] 6.7
Capital World Investors Gilead Sciences Inc [2023-02-13] 5.5
Gilead Sciences Inc Arcellx Inc [2023-02-06] 7.3
Gilead Sciences Inc Allovir Inc [2022-08-08] 14.8
BlackRock Inc Gilead Sciences Inc [2022-07-08] 10.1
Gilead Sciences Inc Agenus Inc [2022-02-10] 4.3
Gilead Sciences Inc Tango Therapeutics Inc [2021-09-10] 5.5
Gilead Sciences Inc Jounce Therapeutics Inc [2020-10-26] 13.9
Gilead Sciences Inc Arcus Biosciences Inc [2020-07-17] 35.0
Gilead Sciences Inc Sierra Oncology Inc [2020-02-10] 9.99
Gilead Sciences Inc Galapagos NV [2019-07-23] 12.3
Gilead Sciences Inc Hookipa Pharma Inc [2019-05-03] 7.7
Capital Research Global Investors Gilead Sciences Inc [2019-02-14] 5.6
Gilead Sciences Inc Allogene Therapeutics Inc [2019-02-13] 6.2
Gilead Sciences Inc Agenus Inc [2019-01-29] 0.3
Gilead Sciences Inc Galapagos NV [2016-01-27] 14.8
Vanguard Group Inc Gilead Sciences Inc [2015-02-10] 5.4
Price T Rowe Associates Inc /MD/ Gilead Sciences Inc [2014-02-11] 5.0
FMR LLC Gilead Sciences Inc [2013-02-14] 0.0
Growth Fund of America Inc Gilead Sciences Inc [2013-02-13] 6.8
Capital World Investors Gilead Sciences Inc [2013-02-13] 7.0
Capital Research Global Investors Gilead Sciences Inc [2012-02-14] 5.5
Form 3/4/5 Filer 2011 - 2025
Dickinson Andrew D
Gilead Sciences Inc
Mercier Johanna
O'Day Daniel Patrick
Telman Deborah H
Bluestone Jeffrey
Wilfong Diane E.
Xilio Therapeutics, Inc.
Barton Jacqueline K
Manwani Harish
Horning Sandra
Welters Anthony
Rodriguez Javier
Love Ted W
Kramer Kelly A.
Patterson Sandra
Berger Dietmar
Arcus Biosciences, Inc.
Assembly Biosciences Inc
Parsey Merdad
LEAP Therapeutics Inc
Lofton Kevin E
Kyverna Therapeutics, Inc.
Arcellx, Inc.
HOOKIPA Pharma Inc.
Kalaris Therapeutics, Inc.
Pletcher Brett A
WOLD Olsen PER
Whitley Richard James
Jounce Therapeutics, Inc.
Wilson Gayle E
Cogan John Francis
Hamill Laura
Washington Robin L
Alton Gregg H
McHutchison John G
Martin John C
Milligan John F
Moore Nicholas G
Bischofberger Norbert W
Young Kevin
Meyers James R
Madigan John W
Carter Paul Rutherford
Hills Carla A
Davignon Etienne
Denny James M
Metza Kristen
Moore Gordon Earle
Form 13F Holdings
Firm Period DFND Voting Shares
BlackRock, Inc. [2025-06-30] SOLE 103,260,674 114,878,166
Vanguard Group Inc [2025-06-30] SOLE 0 113,095,884
FMR LLC [2025-06-30] DFND 51,918,315 59,955,377
State Street Corp [2025-06-30] DFND 35,410,023 59,188,160
Capital World Investors [2025-06-30] DFND 46,012,805 46,303,299
Wellington Management Group LLP [2025-06-30] DFND 0 37,530,510
Capital Research Global Investors [2025-06-30] DFND 31,091,248 31,097,679
Dodge & Cox [2025-06-30] SOLE 29,619,922 30,818,322
Geode Capital Management LLC [2025-06-30] DFND 29,160,690 29,207,662
Morgan Stanley [2025-06-30] DFND 12,775,998 22,835,109
Norges Bank [2025-06-30] SOLE 19,394,502 19,394,502
Bank of America Corp /DE/ [2025-06-30] DFND 1,333,583 19,191,304
JPMorgan Chase & Co [2025-06-30] DFND 15,845,423 19,047,509
Northern Trust Corp [2025-06-30] DFND 13,817,987 13,953,345
Invesco Ltd. [2025-06-30] DFND 0 13,521,228
Bank of New York Mellon Corp [2025-06-30] DFND 11,369,426 13,165,909
Amundi [2025-06-30] DFND 10,467,411 10,467,411
Legal & General Group Plc [2025-06-30] DFND 9,016,797 9,796,145
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME [2025-06-30] SOLE 5,556,516 8,782,920
Citadel Advisors LLC [2025-06-30] DFND 8,640,245 8,640,245
Charles Schwab Investment Management Inc [2025-06-30] SOLE 7,999,762 8,000,074
Dimensional Fund Advisors LP [2025-06-30] SOLE 7,509,120 7,869,855
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME [2025-06-30] DFND 3,903,666 7,461,852
Ameriprise Financial Inc [2025-06-30] DFND 0 6,748,403
Wells Fargo & Company/MN [2025-06-30] DFND 519,540 6,470,688
Royal Bank of Canada [2025-06-30] DFND 6,170,499 6,417,919
Allianz Asset Management GmbH [2025-06-30] DFND 3,367,128 6,361,717
Vanguard Group Inc [2025-06-30] DFND 1,872 6,268,342
Goldman Sachs Group Inc [2025-06-30] DFND 6,032,622 6,260,360
AllianceBernstein LP [2025-06-30] DFND 5,439,967 6,144,790
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com